Detalus Advisors’s Elevance Health ELV Stock Holding History

Detalus Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$658K	Hold	1,694	–	–	0.13%	82
2026 Q2	$655K	Buy	1,694 +1	+0.1%	+$371	0.13%	79
2026 Q1	$496K	Buy	1,693 +1	+0.1%	+$329	0.11%	97
2025 Q4	$593K	Sell	1,692 -34	-2%	-$11.5K	0.14%	80
2025 Q3	$558K	Buy	1,726 +31	+2%	+$9.6K	0.14%	78
2025 Q2	$659K	Hold	1,695	–	–	0.19%	68
2025 Q1	$737K	Hold	1,695	–	–	0.23%	61
2024 Q4	$625K	Sell	1,695 -112	-6%	-$46.9K	0.21%	66
2024 Q3	$940K	Hold	1,807	–	–	0.31%	44
2024 Q2	$979K	Buy	1,807 +154	+9%	+$81.4K	0.34%	45
2024 Q1	$857K	Hold	1,653	–	–	0.31%	46
2023 Q4	$780K	Buy	1,653 +36	+2%	+$16.6K	0.31%	49
2023 Q3	$704K	Buy	1,617 +4	+0.2%	+$1.81K	0.33%	56
2023 Q2	$717K	Buy	1,613 +45	+3%	+$20.8K	0.32%	54
2023 Q1	$721K	Buy	+1,568	New	+$746K	0.34%	54

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

ACR Alpine Capital Research St. Louis, Missouri $7.35B AUM 21.37% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

High Ground Investment Management London, United Kingdom $1.3B AUM 17.7% 1-Year Est. Return

Detalus Advisors's ELV Position: Q3 2026 in Review

Detalus Advisors held its Elevance Health (ELV) position steady in Q3 2026 at 1,694 shares worth $658K. The position accounts for 0.13% of the portfolio, ranked #82.

Detalus Advisors first reported a position in ELV in Q1 2023 and has held it in 15 quarters since. The position peaked at $979K in Q2 2024. 866 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Detalus Advisors held 1,694 shares of Elevance Health worth $658K as of Q3 2026.
Detalus Advisors left its Elevance Health share count unchanged in Q3 2026.
Elevance Health made up 0.13% of Detalus Advisors's portfolio in Q3 2026, its #82 holding.
Detalus Advisors first reported a position in Elevance Health in Q1 2023 and has held it in 15 quarters since.
Detalus Advisors's Elevance Health position peaked at $979K in Q2 2024.
866 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Detalus Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.